Your browser doesn't support javascript.
loading
Phase II study of the efficacy and safety of lenvatinib for anaplastic thyroid cancer (HOPE).
Higashiyama, Takuya; Sugino, Kiminori; Hara, Hisato; Ito, Ken-Ichi; Nakashima, Noriaki; Onoda, Naoyoshi; Tori, Masayuki; Katoh, Hiroshi; Kiyota, Naomi; Ota, Ichiro; Suganuma, Nobuyasu; Hibi, Yatsuka; Nemoto, Toshimitsu; Takahashi, Shunji; Yane, Katsunari; Ioji, Tetsuya; Kojima, Shinsuke; Kaneda, Hideaki; Sugitani, Iwao; Tahara, Makoto.
Afiliación
  • Higashiyama T; Department of Surgery, Kuma Hospital, Kobe, Japan. Electronic address: higashiyama@kuma-h.or.jp.
  • Sugino K; Department of Surgery, Ito Hospital, Tokyo, Japan.
  • Hara H; Department of Breast and Endocrine Surgery, Tsukuba University, Tsukuba, Japan.
  • Ito KI; Division of Breast and Endocrine Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
  • Nakashima N; Division of Surgical Oncology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
  • Onoda N; Department of Surgery, Kuma Hospital, Kobe, Japan; Department of Breast & Endocrine Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Tori M; Department of Endocrine Surgery, Osaka Police Hospital, Osaka, Japan.
  • Katoh H; Department of Breast and Endocrine Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
  • Kiyota N; Oncology/Hematology, Kobe University Hospital Cancer Center, Kobe, Japan.
  • Ota I; Nara Medical University, Kashihara, Japan.
  • Suganuma N; Kanagawa Cancer Center, Yokohama, Japan.
  • Hibi Y; Fujita Health University Hospital, Toyoake, Japan.
  • Nemoto T; Department of Otorhinolaryngology, Japanese Red Cross Narita Hospital, Chiba, Japan.
  • Takahashi S; Department of Medical Oncology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Yane K; Department of Otolaryngology-Head and Neck Surgery, Kindai University Nara Hospital, Ikoma, Japan.
  • Ioji T; Translational Research Center for Medical Innovation, Kobe, Japan.
  • Kojima S; Translational Research Center for Medical Innovation, Kobe, Japan.
  • Kaneda H; Translational Research Center for Medical Innovation, Kobe, Japan.
  • Sugitani I; Department of Endocrine Surgery, Nippon Medical School, Tokyo, Japan.
  • Tahara M; Department of Head and Neck Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
Eur J Cancer ; 173: 210-218, 2022 09.
Article en En | MEDLINE | ID: mdl-35932627
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinolinas / Neoplasias de la Tiroides / Carcinoma Anaplásico de Tiroides / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Quinolinas / Neoplasias de la Tiroides / Carcinoma Anaplásico de Tiroides / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Eur J Cancer Año: 2022 Tipo del documento: Article